Ernexa Therapeutics Inc. - 31ERNAWPreferred / convertible
13F holders, Q1 2026 (March 31)5holders
$0.03avg. 13F price*
At the end of Q1 2026, 5 institutions reported holding Ernexa Therapeutics Inc. - 31 (ERNAW) in their 13F filings. The largest holders were Armistice Capital, LLC ($112K), Bleichroeder LP ($56K) and Heights Capital Management, Inc. ($16K).
- Company
- Ernexa Therapeutics Inc. - 31
- CUSIP
- 114082118
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $195K |
| Exits | 0 | $0 |
Ownership 5 holders
| Armistice Capital, LLC | — | New | 4,000,000 | $112K |
| Bleichroeder LP | — | New | 2,000,000 | $56K |
| Heights Capital Management, Inc. | — | New | 400,000 | $16K |
| Warberg Asset Management LLC | — | New | 253,800 | $7K |
| Clear Street Group Inc. | — | New | 149,300 | $4K |
"% of holder's portfolio" is ERNAW's weight in each manager's 13F, not the share of Ernexa Therapeutics Inc. - 31 the manager owns.